Women and bleeding disorders

Haemophilia

Volumn 16, Issue SUPPL. 5, 2010, Pages 160-167

  James, A H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bleeding disorders; Menorrhagia; Postpartum haemorrhage; Von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 13; ETHINYLESTRADIOL; ETONOGESTREL; FIBRINOGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; TRANEXAMIC ACID;

BLEEDING DISORDER; CHILDBIRTH; CLINICAL TRIAL; CURETTAGE; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENDOMETRIUM ABLATION; FEMALE; HEMATOMA; HEMOPHILIA; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; ORAL CONTRACEPTION; OVARY CYST; PERINEAL HEMATOMA; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS; FEMALE; GYNECOLOGY; HEMORRHAGIC DISORDERS; HUMANS; MENORRHAGIA; OBSTETRICS; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; VON WILLEBRAND DISEASES;

EID: 77955030403     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02315.x     Document Type: Review

References (76)

1. Edlund M, Blomback M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996, 53:234-8.
2. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998, 351:485-9.
3. Goodman-Gruen D, Hollenbach K. The Prevalence of von Willebrand disease in women with abnormal uterine bleeding. J Womens Health Gend Based Med 2001, 10:677-80.
4. Dilley A, Drews C, Miller C. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001, 97:630-6.
5. Woo YL, White B, Corbally R. von Willebrand's disease: an important cause of dysfunctional uterine bleeding. Blood Coagul Fibrinolysis 2002, 13:89-93.
6. Philipp CS, Dilley A, Miller CH. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost 2003, 1:477-84.
7. James AH, Lukes AS, Brancazio LR, Thames E, Ortel TL. Use of a new platelet function analyzer to detect von Willebrand disease in women with menorrhagia. Am J Obstet Gynecol 2004, 191:449-55.
8. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004, 111:734-40.
9. Management of Anovulatory Bleeding 2000, Washington, DC, American College of Obstetricians and Gynecologists
10. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990, 97:734-9.
11. Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995, 85:977-82.
12. Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG 2000, 107:320-2.
13. Kingman CE, Kadir RA, Lee CA, Economides DL. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. BJOG 2004, 111:1425-8.
14. Kouides PA, Heit JA, Philipp CS. A multi-site, prospective cross-over study of intranasal desmopressin and oral tranexamic acid in women with menorrhagia and abnormal laboratory hemostasis. Blood 2007, 110. ASH Annual Meeting Abstracts
15. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004, 190:1216-23.
16. Philipp CS, Faiz A, Dowling NF. Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. Am J Obstet Gynecol 2008, 198:163.e1-8.
17. Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973, 238:1-159.
18. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005, 11:295-307.
19. Gomez A, Lucia JF, Perella M, Aguilar C. Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease. Haemophilia 1998, 4:60-2.
20. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991, 98:909-18.
21. Jarvis RR, Olsen ME. Type I von Willebrand's disease presenting as recurrent corpus hemorrhagicum. Obstet Gynecol 2002, 99(5 Pt 2):887-8.
22. Ghosh K, Mohanty D, Pathare AV, Jijina F. Recurrent haemoperitoneum in a female patient with type III von Willebrand's disease responded to administration of oral contraceptive. Haemophilia 1998, 4:767-8.
23. Bottini E, Pareti FI, Mari D, Mannucci PM, Muggiasca ML, Conti M. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports. Haematologica 1991, 76:431-3.
24. Kirtava A, Drews C, Lally C, Dilley A, Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia 2003, 9:292-7.
25. Lobo RA. Endometriosis: etiology, pathology, diagnosis, managment. Katz: Comprehensive Gynecology 2007, 473-95. Katz V. eds, 5th edn, Philadelphia, Mosby
26. Vercellini P, De Giorgi O, Aimi G, Panazza S, Uglietti A, Crosignani PG. Menstrual characteristics in women with and without endometriosis. Obstet Gynecol 1997, 90:264-8.
27. Chuong CJ, Brenner PF. Management of abnormal uterine bleeding. Am J Obstet Gynecol 1996, 175(3 Pt 2):787-92.
28. Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995, 35:209-19.
29. Siegel JE, Kouides PA. Menorrhagia from a haematologist's point of view. Part II: management. Haemophilia 2002, 8:339-47.
30. Foster PA. The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995, 74:784-90.
31. Beller FK, Ebert C. Effects of oral contraceptives on blood coagulation. A review. Obstet Gynecol Surv 1985, 40:425-36.
32. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999, 82:1456-61.
33. Middeldorp S, Meijers JC, van den Ende AE. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost 2000, 84:4-8.
34. Edelman AB, Koontz SL, Nichols MD, Jensen JT. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given? Obstet Gynecol 2006, 107:657-65.
35. Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002, 288:1610-21.
36. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002, 81:799-816.
37. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999, 5:40-8.
38. El-Nashar SA, Hopkins MR, Feitoza SS. Global endometrial ablation for menorrhagia in women with bleeding disorders. Obstet Gynecol 2007, 109:1381-7.
39. Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis. Obstet Gynecol 2009, 113:1104-16.
40. Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997, 90:257-63.
41. James AH, Myers ER, Cook C, Pietrobon R. Complications of hysterectomy in women with von Willebrand disease. Haemophilia 2009, 15:926-31.
42. Evron S, Anteby SO, Brzezinsky A, Samueloff A, Eldor A. Congenital afibrinogenemia and recurrent early abortion: a case report. Eur J Obstet Gynecol Reprod Biol 1985, 19:307-11.
43. Inamoto Y, Terao T. First report of case of congenital afibrinogenemia with successful delivery. Am J Obstet Gynecol 1985, 153:803-4.
44. Goodwin TM. Congenital hypofibrinogenemia in pregnancy. Obstet Gynecol Surv 1989, 44:157-61.
45. Trehan AK, Fergusson IL. Congenital afibrinogenaemia and successful pregnancy outcome. Case report. Br J Obstet Gynaecol 1991, 98:722-4.
46. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999, 107:p.
47. Kobayashi T, Asahina T, Maehara K, Itoh M, Kanayama N, Terao T. Congenital afibrinogenemia with successful delivery. Gynecol Obstet Invest 1996, 42:66-9.
48. Grech H, Majumdar G, Lawrie AS, Savidge GF. Pregnancy in congenital afibrinogenaemia: report of a successful case and review of the literature. Br J Haematol 1991, 78:571-2.
49. Kobayashi T, Kanayama N, Tokunaga N, Asahina T, Terao T. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol 2000, 109:364-6.
50. Yamanaka Y, Takeuchi K, Sugimoto M, Sato A, Nakago S, Maruo T. Dysfibrinogenemia during pregnancy treated successfully with fibrinogen. Acta Obstet Gynecol Scand 2003, 82:972-3.
51. Roque H, Stephenson C, Lee MJ. Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies. Am J Hematol 2004, 76:267-70.
52. Rodeghiero F, Castaman GC, Di Bona E, Ruggeri M, Dini E. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case. Blut 1987, 55:45-8.
53. Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990, 29:235-8.
54. Burrows RF, Ray JG, Burrows EA. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv 2000, 55:103-8.
55. Inbal A, Kenet G. Pregnancy and surgical procedures in patients with factor XIII deficiency. Biomedical Progress 2003, 16:69-71.
56. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007, 5:1165-9.
57. Edwards A, Ellwood DA. Ultrasonographic evaluation of the postpartum uterus. Ultrasound Obstet Gynecol 2000, 16:640-3.
58. Marchant S, Alexander J, Garcia J, Ashurst H, Alderdice F, Keene J. A survey of women's experiences of vaginal loss from 24 hours to three months after childbirth (the BLiPP study). Midwifery 1999, 15:72-81.
59. Visness CM, Kennedy KI, Ramos R. The duration and character of postpartum bleeding among breast-feeding women. Obstet Gynecol 1997, 89:159-63.
60. Dahlman T, Hellgren M, Blomback M. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecol Obstet Invest 1985, 20:37-44.
61. Lee CY, Madrazo B, Drukker BH. Ultrasonic evaluation of the postpartum uterus in the management of postpartum bleeding. Obstet Gynecol 1981, 58:227-32.
62. Hoveyda F, MacKenzie IZ. Secondary postpartum haemorrhage: incidence, morbidity and current management. BJOG 2001, 108:927-30.
63. Ramsahoye B, Davies S, Dasani H, Pearson J. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1995, 1:140-4.
64. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998, 105:314-21.
65. Kadir RA, Economides DL, Braithwaite J, Goldman E, Lee CA. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997, 104:803-10.
66. Kadir RA. Women and inherited bleeding disorders: pregnancy and delivery. Semin Hematol 1999, 36(3 Suppl. 4):28-35.
67. Michaelides K, Tuddenham EG, Turner C, Lavender B, Lavery SA. Live birth following the first mutation specific pre-implantation genetic diagnosis for haemophilia A. Thromb Haemost 2006, 95:373-9.
68. Mannucci PM. How I treat patients with von Willebrand disease. Blood 2001, 97:1915-9.
69. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv 1998, 53:450-5.
70. Chediak JR, Alban GM, Maxey B. von Willebrand's disease and pregnancy: management during delivery and outcome of offspring. Am J Obstet Gynecol 1986, 155:618-24.
71. Sanchez-Luceros A, Meschengieser SS, Turdo K. Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history. Thromb Res 2007, 120:387-90.
72. Roque H, Funai E, Lockwood CJ. von Willebrand disease and pregnancy. J Matern Fetal Med 2000, 9:257-66.
73. Kouides PA. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol 2001, 14:381-99.
74. James AH. Guidelines for bleeding disorders in women. Thromb Res 2009, 123(Suppl. 2):S124-8.
75. Nichols WL, Hultin MB, James AH. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008, 14:171-232.
76. Krause M, Aygroren-Pursun E, Ehrenforth S. Inherited and acquired coagulation disorders in women with menorrhagia. Thromb and Haemost 2001, 865:1137.